Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1381 to 1384 of 1384 entries
Sorted by: Best Match Show Resources per page
Autologous Adipose-Derived Mesenchymal Stem Cells Combined with Shockwave Therapy Synergistically Ameliorates the Osteoarthritic Pathological Factors in Knee Joint.

Pharmaceuticals (Basel, Switzerland)

Cheng JH, Yen KT, Chou WY, Jhan SW, Hsu SL, Ko JY, Wang CJ, Kuo CA, Wu SY, Hsu TC, Hsu CC.
PMID: 33916108
Pharmaceuticals (Basel). 2021 Apr 01;14(4). doi: 10.3390/ph14040318.

Adipose-derived mesenchymal stem cells (ADSCs) and shockwave (SW) therapy have been shown to exert a chondroprotective effect for osteoarthritis (OA). The results of this study demonstrated that autologous ADSCs had dose-dependent and synergistic effects with SW therapy (0.25 mJ/mm

Cite
Cheng JH, Yen KT, Chou WY, et al. Autologous Adipose-Derived Mesenchymal Stem Cells Combined with Shockwave Therapy Synergistically Ameliorates the Osteoarthritic Pathological Factors in Knee Joint. Pharmaceuticals (Basel). 2021;14(4)doi: 10.3390/ph14040318.
Cheng, J. H., Yen, K. T., Chou, W. Y., Jhan, S. W., Hsu, S. L., Ko, J. Y., Wang, C. J., Kuo, C. A., Wu, S. Y., Hsu, T. C., & Hsu, C. C. (2021). Autologous Adipose-Derived Mesenchymal Stem Cells Combined with Shockwave Therapy Synergistically Ameliorates the Osteoarthritic Pathological Factors in Knee Joint. Pharmaceuticals (Basel, Switzerland), 14(4), . https://doi.org/10.3390/ph14040318
Cheng, Jai-Hong, et al. "Autologous Adipose-Derived Mesenchymal Stem Cells Combined with Shockwave Therapy Synergistically Ameliorates the Osteoarthritic Pathological Factors in Knee Joint." Pharmaceuticals (Basel, Switzerland) vol. 14,4 (2021). doi: https://doi.org/10.3390/ph14040318
Cheng JH, Yen KT, Chou WY, Jhan SW, Hsu SL, Ko JY, Wang CJ, Kuo CA, Wu SY, Hsu TC, Hsu CC. Autologous Adipose-Derived Mesenchymal Stem Cells Combined with Shockwave Therapy Synergistically Ameliorates the Osteoarthritic Pathological Factors in Knee Joint. Pharmaceuticals (Basel). 2021 Apr 01;14(4). doi: 10.3390/ph14040318. PMID: 33916108; PMCID: PMC8065528.
Copy Download .nbib Format: NLM
Incidence and prognostic significance of extranodal extension in isolated nodal recurrence of oral squamous cell carcinoma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Chang CW, Wang C, Lu CJ, Wang CW, Wu CT, Wang CP, Yang TL, Lou PJ, Ko JY, Chang YL, Chen TC.
PMID: 34902369
Radiother Oncol. 2021 Dec 10;167:81-88. doi: 10.1016/j.radonc.2021.12.008. Epub 2021 Dec 10.

BACKGROUND: Extranodal extension (ENE) is a crucial prognostic factor of oral squamous cell carcinoma (OSCC). However, the role of ENE in regional recurrence (rENE) remains unclear. The purpose of our study is to assess the salvage outcome according to...

Cite
Chang CW, Wang C, Lu CJ, et al. Incidence and prognostic significance of extranodal extension in isolated nodal recurrence of oral squamous cell carcinoma. Radiother Oncol. 2021;167:81-88doi: 10.1016/j.radonc.2021.12.008.
Chang, C. W., Wang, C., Lu, C. J., Wang, C. W., Wu, C. T., Wang, C. P., Yang, T. L., Lou, P. J., Ko, J. Y., Chang, Y. L., & Chen, T. C. (2021). Incidence and prognostic significance of extranodal extension in isolated nodal recurrence of oral squamous cell carcinoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 16781-88. https://doi.org/10.1016/j.radonc.2021.12.008
Chang, Chun-Wei, et al. "Incidence and prognostic significance of extranodal extension in isolated nodal recurrence of oral squamous cell carcinoma." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 167 (2021): 81-88. doi: https://doi.org/10.1016/j.radonc.2021.12.008
Chang CW, Wang C, Lu CJ, Wang CW, Wu CT, Wang CP, Yang TL, Lou PJ, Ko JY, Chang YL, Chen TC. Incidence and prognostic significance of extranodal extension in isolated nodal recurrence of oral squamous cell carcinoma. Radiother Oncol. 2021 Dec 10;167:81-88. doi: 10.1016/j.radonc.2021.12.008. Epub 2021 Dec 10. PMID: 34902369.
Copy Download .nbib Format: NLM
Diallyl disulfide prevents 1,3-dichloro-2-propanol-induced hepatotoxicity through mitogen-activated protein kinases signaling.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association

Kim JW, Kim JH, Kim CY, Jeong JS, Lim JO, Kim JC, Ko JW, Kim TW.
PMID: 34999178
Food Chem Toxicol. 2022 Jan 06;160:112814. doi: 10.1016/j.fct.2022.112814. Epub 2022 Jan 06.

We investigated whether diallyl disulfide (DADS) has protective effects against 1,3-dichloro-2-propanol (1,3-DCP)-induced hepatotoxicity and oxidative damage in rats and HepG2 cells. DADS was administered to rats once daily for 7 days at doses of 30 and 60 mg/kg/day. One...

Cite
Kim JW, Kim JH, Kim CY, et al. Diallyl disulfide prevents 1,3-dichloro-2-propanol-induced hepatotoxicity through mitogen-activated protein kinases signaling. Food Chem Toxicol. 2022;160:112814doi: 10.1016/j.fct.2022.112814.
Kim, J. W., Kim, J. H., Kim, C. Y., Jeong, J. S., Lim, J. O., Kim, J. C., Ko, J. W., & Kim, T. W. (2022). Diallyl disulfide prevents 1,3-dichloro-2-propanol-induced hepatotoxicity through mitogen-activated protein kinases signaling. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 160112814. https://doi.org/10.1016/j.fct.2022.112814
Kim, Jeong-Won, et al. "Diallyl disulfide prevents 1,3-dichloro-2-propanol-induced hepatotoxicity through mitogen-activated protein kinases signaling." Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association vol. 160 (2022): 112814. doi: https://doi.org/10.1016/j.fct.2022.112814
Kim JW, Kim JH, Kim CY, Jeong JS, Lim JO, Kim JC, Ko JW, Kim TW. Diallyl disulfide prevents 1,3-dichloro-2-propanol-induced hepatotoxicity through mitogen-activated protein kinases signaling. Food Chem Toxicol. 2022 Jan 06;160:112814. doi: 10.1016/j.fct.2022.112814. Epub 2022 Jan 06. PMID: 34999178.
Copy Download .nbib Format: NLM
Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature.

Journal of pediatric hematology/oncology

Choi S, Hong KT, Choi JY, Ahn HY, Ko JS, Suh KS, Park SH, Cheon JE, Shin HY, Kang HJ.
PMID: 33769384
J Pediatr Hematol Oncol. 2021 Oct 01;43(7):e1015-e1019. doi: 10.1097/MPH.0000000000002121.

Posttransplant lymphoproliferative disorder (PTLD) is a heterogeneous group of diseases with abnormal proliferation of lymphoid tissue and classical Hodgkin lymphoma (CHL) type PTLD is a very rare subtype. We describe a successfully diagnosed and treated CHL-PTLD stage IV pediatric...

Cite
Choi S, Hong KT, Choi JY, et al. Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2021;43(7):e1015-e1019doi: 10.1097/MPH.0000000000002121.
Choi, S., Hong, K. T., Choi, J. Y., Ahn, H. Y., Ko, J. S., Suh, K. S., Park, S. H., Cheon, J. E., Shin, H. Y., & Kang, H. J. (2021). Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature. Journal of pediatric hematology/oncology, 43(7), e1015-e1019. https://doi.org/10.1097/MPH.0000000000002121
Choi, Sujin, et al. "Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature." Journal of pediatric hematology/oncology vol. 43,7 (2021): e1015-e1019. doi: https://doi.org/10.1097/MPH.0000000000002121
Choi S, Hong KT, Choi JY, Ahn HY, Ko JS, Suh KS, Park SH, Cheon JE, Shin HY, Kang HJ. Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2021 Oct 01;43(7):e1015-e1019. doi: 10.1097/MPH.0000000000002121. PMID: 33769384.
Copy Download .nbib Format: NLM
Showing 1381 to 1384 of 1384 entries